AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$30.78
−$0.55 (−1.74%) 4:00 PM ET
After hours$30.75
−$0.03 (−0.11%) 8:25 PM ET
Prev closePrevC$31.33
OpenOpen$30.91
Day highHigh$31.05
Day lowLow$30.56
VolumeVol711,208
Avg volAvgVol1,003,433
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$38.73B
Sector
Financials
AI report sections
MIXED
PUK
Prudential plc
The share price is trading near its 52-week high after a sharp 12-month gain of over 100%, with multiple bullish technical signals pointing to a prevailing upward trend. At the same time, overbought momentum readings and an elevated intraday short volume ratio indicate a more fragile near-term backdrop. The balance sheet shows positive equity and moderate long-term debt, but the absence of detailed earnings and cash-flow metrics limits deeper fundamental assessment.
AI summarized at 4:35 PM ET, 2026-01-29
AI summary scores
INTRADAY:63SWING:78LONG:69
Volume vs average
Intraday (cumulative)
−19% (Below avg)
Vol/Avg: 0.81×
RSI
49.73(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.02 (Strong)
MACD: 0.01 Signal: -0.01
Short-Term
-0.07 (Weak)
MACD: -0.30 Signal: -0.23
Long-Term
-0.18 (Weak)
MACD: 0.06 Signal: 0.24
Intraday trend score
45.38
LOW35.38HIGH59.38
Latest news
PUK•12 articles•Positive: 1Neutral: 1Negative: 0
NeutralGlobeNewswire Inc.• Sns Insider
Critical Illness Insurance Market to Reach USD 659.84 Billion by 2033, Growing at 9.01% CAGR – SNS Insider
The global critical illness insurance market is projected to grow from USD 332.3 billion in 2025 to USD 659.84 billion by 2033, driven by rising disease prevalence, escalating healthcare costs, and digital distribution channels. The U.S. market alone is expected to reach USD 173.54 billion by 2033. Growth is fueled by increasing awareness, employer-sponsored benefits, and technological innovations in claims processing, though regulatory complexity and lack of standardized coverage definitions pose challenges.
AFLALIZYAIGMETcritical illness insurancemarket growthhealthcare costsdigital distribution
Sentiment note
Identified as major player in the growing market but no specific developments or strategic initiatives highlighted.
PositiveGlobeNewswire Inc.• Globe Newswire
$75+ Bn Cancer Insurance Markets, 2018-2023, 2023-2028F, 2033F
The cancer insurance market is expected to grow strongly in the coming years, driven by factors such as rising cancer incidence rates, medical inflation, and heightened awareness. Key trends include innovative product developments, customizable policies, and integration with health plans. The increasing number of cancer cases is a major driver for the market's growth.
Prudential plc is mentioned as one of the key players in the cancer insurance market, implying their involvement and potential to benefit from the market's growth.
UnknownSeeking Alpha• Millennial Dividends
A Deep Dive Into Investing Strategies For A Rich Retirement
Check here to learn more about the key strategies for successful retirement planning in the face of high inflation and rising home prices.
ABBVAMGNARCCAVGO
UnknownZacks Investment Research• Zacks Equity Research
What Makes Prudential (PUK) a New Buy Stock
Prudential (PUK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PUK
UnknownZacks Investment Research• Zacks Equity Research
EG or PUK: Which Is the Better Value Stock Right Now?
EG vs. PUK: Which Stock Is the Better Value Option?
EGPUK
UnknownZacks Investment Research• Zacks Equity Research
AGESY vs. PUK: Which Stock Is the Better Value Option?
AGESY vs. PUK: Which Stock Is the Better Value Option?
PUK
UnknownZacks Investment Research• Zacks Equity Research
AGESY vs. PUK: Which Stock Should Value Investors Buy Now?
AGESY vs. PUK: Which Stock Is the Better Value Option?
PUK
UnknownBenzinga• Lisa Levin
Unity Software, Tigo Energy And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session.
Unity Software Inc. (NYSE: U) shares surged 6.7% to $31.70 in pre-market trading after the company announced a CEO transition. Unity announced that John Riccitiello will retire as chairman, president and CEO, effective immediately.
Hertz Global Holdings, Inc. (NYSE: HTZ) gained 5.6% to $11.71 in pre-market trading. Hertz Global is scheduled ...
MORHTZNOKPUKNewsPenny StocksSmall CapPre-Market Outlook
UnknownZacks Investment Research• Zacks Equity Research
MET vs. PUK: Which Stock Should Value Investors Buy Now?
MET vs. PUK: Which Stock Is the Better Value Option?
METPUK
UnknownZacks Investment Research• Zacks Equity Research
CRBG vs. PUK: Which Stock Is the Better Value Option?
CRBG vs. PUK: Which Stock Is the Better Value Option?
CRBGPUK
UnknownZacks Investment Research• Zacks Equity Research
AIZ vs. PUK: Which Stock Is the Better Value Option?
AIZ vs. PUK: Which Stock Is the Better Value Option?
AIZPUK
UnknownBenzinga• Lisa Levin
Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
PTC Therapeutics, Inc. (NASDAQ: PTCT) shares dipped 21.3% to $46.00 in pre-market trading after the company announced its MOVE-FA trial of vatiquinone did not meet its primary endpoint. The company will discontinue its preclinical and early research gene therapy programs.
Global Net Lease, Inc. (NYSE: GNL) shares fell 10.4% to $9.46 ...
MORAPUKPTCTNewsPenny StocksSmall CapPre-Market Outlook
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
